CBD and THC are the two best-known cannabinoids of several hundred derived from the hemp plant. Cannabinoids are active chemical substances acting on receptors in the body such as the nervous system, organs, immune system, etc.).
However, unlike THC (tetrahydrocannabinol) which has psychotropic effects, hilarious and which modifies the consumer’s state of consciousness, CBD (cannabidiol) does not present any danger to the body.
In most countries, THC is considered a drug. It is because of its psychoactive effects, the dependence it creates and generally the risks it poses to the body that THC is often illegal. It is the opposite for CBD although it is also attributed sedative properties.
When it comes to CBD, research into its potential is just beginning. It is already attributed with anxiolytic, antidepressant, anti-stress, antipsychotic, antiepileptic, anti-inflammatory, analgesic, sleep, and addiction effects (see article “CBD: what are the effects?”)
In France, CBD cannot, to date, be considered a medicine and falls into the category of food supplements. It is therefore not possible to boast of the beneficial therapeutic effects of this molecule. Ongoing studies and their results on the virtues of CBD should change the regulations on this subject.